| | 851199-59-2 Basic information More.. |
| Product Name: | Linaclotide | | Synonyms: | Linacllotide;Linaclotide;Linaelotide Acetate;Linaelotide;CY-14;Liclotide;Argpessin;L-Tyrosine, L-cysteinyl-L-cysteinyl-L-α-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (1→6),(2→10),(5→13)-tris(disulfide) | | CAS: | 851199-59-2 | | MF: | C59H79N15O21S6 | | MW: | 1526.74 | | EINECS: | 251-228-4 | | Mol File: | 851199-59-2.mol |  |
Use
In August 2012, the US FDA approved linaclotide (also referred to as MD-1100), a first-in-class, orally administered 14-amino acid peptide as a therapy for patients suffering from chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).
- Linaclotide
-
- 2025-09-01
- CAS:851199-59-2
- Min. Order:
- Purity: 0.99
- Supply Ability:
- Linaclotide
-
- US $0.00 / g
- 2025-09-01
- CAS:851199-59-2
- Min. Order: 1g
- Purity: 98%min
- Supply Ability: 100g
- Linaclotide
-
- US $0.00-0.00 / G
- 2025-09-01
- CAS:851199-59-2
- Min. Order: 1G
- Purity: 99%
- Supply Ability: 1000G
|
|
851199-59-2
Recommend Suppliers |
|